Fexofenadine Hydrochloride

DRUG4 trials

Sponsors

Moderna Inc., Dr. Reddy's Laboratories Limited, University Ghent, Second Affiliated Hospital, Zhejiang University, School of Medicine

Conditions

Exercise TrainingHealthyPhysical ActivityST-segment Elevation Myocardial Infarction (STEMI)participants with isolated methylmalonic acidemia (MMA) due to methylmalonyl-coenzyme A mutase (MUT) deficiency

Phase 1

Bioequivalence Study of Fexofenadine Hydrochloride Orally Disintegrated Tablets 30 mg Under Fasting Condition

CompletedNCT01888718

Dr. Reddy's Laboratories LimitedHealthy

Start: 2011-02-28End: 2011-03-31Updated: 2013-06-28

A Phase 1/2, Global, Open-Label, Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705.

RecruitingCTIS2022-501997-20-00

Moderna Inc.participants with isolated methylmalonic acidemia (MMA) due to methylmalonyl-coenzyme A mutase (MUT) deficiency

Start: 2023-12-01Target: 26Updated: 2025-12-12

Phase 2

Effect and Safety of Fexofenadine Hydrochloride vs Placebo in Patients With Acute Myocardial Infaction: A Randomized Clinical Trial

RecruitingNCT06548204

Second Affiliated Hospital, Zhejiang University, School of MedicineST-segment Elevation Myocardial Infarction (STEMI)

Start: 2025-01-20End: 2027-12-30Target: 152Updated: 2026-08-10

Unknown Phase

Histamine H1/H2 Receptors and Training Adaptations

CompletedNCT04450134

University GhentExercise Training, Physical Activity

Start: 2019-10-02End: 2021-04-14Updated: 2024-06-07